Newly identified adverse events of enzalutamide using the food and drug administration adverse event reporting system (Unbekannt)
- Neue Suche nach: Wang, Xin
- Neue Suche nach: Chang, Lina
- Neue Suche nach: Li, Zhenhua
- Neue Suche nach: Jiang, Yuanfang
- Neue Suche nach: Chen, Yue
- Neue Suche nach: Jia, Xinli
- Neue Suche nach: Wang, Qiye
- Neue Suche nach: Ren, Xiaolu
- Neue Suche nach: Ma, Zhifang
- Neue Suche nach: Zhang, Wei
- Neue Suche nach: Wang, Xin
- Neue Suche nach: Chang, Lina
- Neue Suche nach: Li, Zhenhua
- Neue Suche nach: Jiang, Yuanfang
- Neue Suche nach: Chen, Yue
- Neue Suche nach: Jia, Xinli
- Neue Suche nach: Wang, Qiye
- Neue Suche nach: Ren, Xiaolu
- Neue Suche nach: Ma, Zhifang
- Neue Suche nach: Zhang, Wei
In:
Expert Opinion on Drug Safety
;
22
, 11
;
1099-1103
;
2023
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Newly identified adverse events of enzalutamide using the food and drug administration adverse event reporting system
-
Beteiligte:Wang, Xin ( Autor:in ) / Chang, Lina ( Autor:in ) / Li, Zhenhua ( Autor:in ) / Jiang, Yuanfang ( Autor:in ) / Chen, Yue ( Autor:in ) / Jia, Xinli ( Autor:in ) / Wang, Qiye ( Autor:in ) / Ren, Xiaolu ( Autor:in ) / Ma, Zhifang ( Autor:in ) / Zhang, Wei ( Autor:in )
-
Erschienen in:Expert Opinion on Drug Safety ; 22, 11 ; 1099-1103
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:02.11.2023
-
Format / Umfang:5 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Unbekannt
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 22, Ausgabe 11
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1003
-
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluationPotestio, Luca / Camela, Elisa / Cacciapuoti, Sara / Martora, Fabrizio / Guerriero, Luigi / Fornaro, Luigi / Ruggiero, Angelo / Megna, Matteo et al. | 2023
- 1011
-
A safety review of current monoclonal antibodies used to treat multiple sclerosisCosta, Gloria Dalla / Comi, Giancarlo et al. | 2023
- 1025
-
An updated safety review of the current drugs for managing ADHD in childrenRyst, Erika / Childress, Ann et al. | 2023
- 1041
-
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of fallsLatt, Nang Khaing Zar / Calvert, Peter / Lip, Gregory Y. H. et al. | 2023
- 1049
-
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaMidha, Shonali / Hartley-Brown, Monique A. / Mo, Clifton C. / Hossain, Shahrier / Nadeem, Omar / O’Donnell, Elizabeth K. / Bianchi, Giada / Sperling, Adam S. / Laubach, Jacob P. / Richardson, Paul G. et al. | 2023
- 1073
-
Safety of current treatment options for NTRK fusion-positive cancersYang, Adeline T. / Laetsch, Theodore Willis et al. | 2023
- 1091
-
Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancySelinger, Christian P / Rosiou, Konstantina / Broglio, Giacomo / Lever, Gillian / Chiu, Chun Ming / Stocker, Linden J / Chipeta, Hlupekile / Glanville, Tracey et al. | 2023
- 1099
-
Newly identified adverse events of enzalutamide using the food and drug administration adverse event reporting systemWang, Xin / Chang, Lina / Li, Zhenhua / Jiang, Yuanfang / Chen, Yue / Jia, Xinli / Wang, Qiye / Ren, Xiaolu / Ma, Zhifang / Zhang, Wei et al. | 2023
- 1105
-
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting SystemBattini, Vera / Carnovale, Carla / Clementi, Emilio / Sessa, Maurizio et al. | 2023
- 1113
-
Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the National Reporting and Learning SystemRowily, Abdulrhman Al / Jalal, Zahraa / Paudyal, Vibhu et al. | 2023
- 1127
-
Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)Wang, Feifei / Xu, Guishui / Wu, Xinan et al. | 2023
- 1133
-
A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting systemWen, Haixiao / Lu, Chong / Zhang, Meng / Qi, Xingling et al. | 2023
- 1143
-
Seizures associated with antibiotics: a real-world disproportionality analysis of FAERS databaseZou, Dan / Zhang, Rui / Yu, Lei / Hu, Tingting / Wu, Bin et al. | 2023